Literature DB >> 2606428

Model-independent pharmacokinetics of colchicine after oral administration to healthy volunteers.

C Girre1, G Thomas, J M Scherrmann, J Crouzette, P E Fournier.   

Abstract

The pharmacokinetics of colchicine were studied after oral administration of three doses (0.5, 1.0 and 1.5 mg) to nine healthy male volunteers according to randomized cross-over design. Plasma and urine samples were collected during 48 h after ingestion, and assayed for colchicine levels by a specific and highly sensitive radio-immunoassay. Pharmacokinetic parameters t1/2 beta, AUC, MRT, CIT/F, CIR, Vd area/F) were calculated by model-independent methods and compared across doses by multiway analysis of variance. Terminal half-life (15.5-19.2 h), mean residence time (15.7-20.3 h), oral systemic (32.2-40.3 l/h) and renal (3.9-4.7 l/h) clearances, and oral volume of distribution (11.4-14.9 l/kg) did not differ significantly between doses, whereas the area under the concentration-time curve was proportional to dose. Our results show that: 1. within the dose range studied (0.5-1.5 mg), the pharmacokinetics of colchicine are linear; 2. monitoring colchicine levels up to 48 hours yields much larger estimates of terminal half-life and volume of distribution than previously reported from considerably shorter studies.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2606428     DOI: 10.1111/j.1472-8206.1989.tb00688.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  7 in total

1.  Different pharmaceutical preparations of colchicine for Familial Mediterranean Fever: are they the same?

Authors:  Hakan Emmungil; Ufuk İlgen; Sezin Turan; Samet Yaman; Orhan Küçükşahin
Journal:  Rheumatol Int       Date:  2019-08-28       Impact factor: 2.631

2.  Pharmacokinetics and absolute bioavailability of colchicine after i.v. and oral administration in healthy human volunteers and elderly subjects.

Authors:  M Rochdi; A Sabouraud; C Girre; R Venet; J M Scherrmann
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

3.  Grapefruit juice and its constituents augment colchicine intestinal absorption: potential hazardous interaction and the role of p-glycoprotein.

Authors:  Arik Dahan; Gordon L Amidon
Journal:  Pharm Res       Date:  2008-12-02       Impact factor: 4.200

4.  Case report: fatal poisoning with Colchicum autumnale.

Authors:  Miran Brvar; Tom Ploj; Gordana Kozelj; Martin Mozina; Marko Noc; Matjaz Bunc
Journal:  Crit Care       Date:  2004-01-02       Impact factor: 9.097

5.  Comparison of the efficacy of once- and twice-daily colchicine dosage in pediatric patients with familial Mediterranean fever--a randomized controlled noninferiority trial.

Authors:  Adem Polat; Cengizhan Acikel; Betul Sozeri; Ismail Dursun; Ozgur Kasapcopur; Nesrin Gulez; Dogan Simsek; Mehmet Saldir; Ipek Dokurel; Hakan Poyrazoglu; Sevcan Bakkaloglu; Ali Delibas; Zelal Ekinci; Nuray A Ayaz; Yasar Kandur; Harun Peru; Yasemin G Kurt; Safiye R Polat; Erbil Unsal; Balahan Makay; Faysal Gok; Seza Ozen; Erkan Demirkaya
Journal:  Arthritis Res Ther       Date:  2016-04-07       Impact factor: 5.156

6.  Colchicine for the treatment of COVID-19 patients: efficacy, safety, and model informed dosage regimens.

Authors:  Eleni Karatza; George Ismailos; Vangelis Karalis
Journal:  Xenobiotica       Date:  2021-04-12       Impact factor: 1.908

7.  Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction.

Authors:  Nathan Mewton; François Roubille; Didier Bresson; Cyril Prieur; Claire Bouleti; Thomas Bochaton; Fabrice Ivanes; Olivier Dubreuil; Loïc Biere; Ahmad Hayek; François Derimay; Mariama Akodad; Benjamin Alos; Lamis Haider; Naoual El Jonhy; Rachel Daw; Charles De Bourguignon; Carole Dhelens; Gérard Finet; Eric Bonnefoy-Cudraz; Gabriel Bidaux; Florent Boutitie; Delphine Maucort-Boulch; Pierre Croisille; Gilles Rioufol; Fabrice Prunier; Denis Angoulvant
Journal:  Circulation       Date:  2021-08-23       Impact factor: 29.690

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.